| Tender Details | ||||||||
|
||||||||
| Deadline * | ||||||||
|
||||||||
| Client Address | ||||||||
|
||||||||
| More Information | ||||||||
| Know More | ||||||||
Similar Tenders
- Ref No: 9868439
- Location: United States
Open Ended School Based Health Center Services Sbhc Rfp
- Deadline: 31 Dec 2099
- Ref No: 4701160
- Location: United States
Broad Agency Announcement National Defense Stockpile Qualification
- Deadline: 30 Mar 2026
- Ref No: 5220319
- Location: Bulgaria
Delivery Of Reagents Medical Products And Bioproducts For Clinical Microbiological Laboratory Blood Center And Pathohistological And Cytological La
- Deadline: 22 Apr 2027
- Ref No: 5226698
- Location: Germany
Medicines With The Active Ingredient Combination Formoterol Glycopyrronium Bromide And Beclometasone Atc R03Al09
- Deadline: 31 Mar 2026
- Ref No: 5976401
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf
- Deadline: 10 May 2026
- Ref No: 5247418
- Location: Bulgaria
Delivery Of Reagents Medical Products And Bioproducts For Clinical Microbiological Laboratory Blood Center And Pathohistological And Cytological La
- Deadline: 22 Apr 2027
- Ref No: 5968352
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acetylcysteine In The Dosage
- Deadline: 10 May 2026
- Ref No: 8287659
- Location: Netherlands
Open House Collective Health Insurance For Low Income Earners Municipal Policy Municipality Of Zutphen
- Deadline: 01 Jul 2028
- Ref No: 4111647
- Location: Canada
E60Hn 21Hdms High Density Mobile Shelving Hdms Rfsa
- Deadline: 15 Dec 2026
- Ref No: 6512253
- Location: United States
Division Of Readiness And Response Science Community Based Solutions And Health Equity Infection Prevention Toolkit
- Deadline: 10 Jul 2027
- Ref No: 5977462
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brimonidine In The Dosage Form
- Deadline: 10 May 2026
- Ref No: 5978310
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg
- Deadline: 10 May 2026
- Ref No: 5978859
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epinephrine In The Dosage Form
- Deadline: 10 May 2026
- Ref No: 7329889
- Location: France
Development Work On Public Spaces Vrd Public Lighting And Low Voltage Lv Network Les Charcoix District In Plessis Pt 91220
- Deadline: 26 Sep 2027
